Literature DB >> 18816502

Avoiding infinite estimates of time-dependent effects in small-sample survival studies.

Georg Heinze1, Daniela Dunkler.   

Abstract

We address the phenomenon of monotone likelihood in Cox regression with time-dependent effects. Monotone likelihood occurs in the fitting process of a Cox model if at least one parameter estimate diverges to +/- infinity. We show that the probability of monotone likelihood is increased by the inclusion of time-dependent effects, particularly in small samples with several unbalanced and highly predictive covariates, and with a high percentage of censoring. Firth's bias reduction procedure was shown to provide an ideal solution to monotone likelihood. Here we extend his idea to Cox regression with time-dependent effects. By penalized maximum likelihood estimation, finite hazard ratio estimates of constant and time-dependent effects can be obtained. Penalized likelihood ratio tests and profile penalized likelihood confidence intervals are proposed as tools for inference. A Monte Carlo study of Cox regression with time-dependent effects confirms advantages of Firth-corrected (FC) over standard Cox analysis in terms of average bias and median absolute deviation. We also compare the FC and standard Cox approaches by means of analyses of two studies with time-dependent effects. An SAS macro and an R package for FC Cox regression with time-varying covariates and time-dependent effects are available at: http://www.muw.ac.at/msi/biometrie/programs. Copyright 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18816502     DOI: 10.1002/sim.3418

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  8 in total

1.  Assessing covariate effects using Jeffreys-type prior in the Cox model in the presence of a monotone partial likelihood.

Authors:  Jing Wu; Mário de Castro; Elizabeth D Schifano; Ming-Hui Chen
Journal:  J Stat Theory Pract       Date:  2017-04-12

2.  Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients.

Authors:  Ayumu Nakashima; Juan Jesús Carrero; Abdul Rashid Qureshi; Tetsu Miyamoto; Björn Anderstam; Peter Bárány; Olof Heimbürger; Peter Stenvinkel; Bengt Lindholm
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 8.237

3.  On maximum likelihood estimation of the semi-parametric Cox model with time-varying covariates.

Authors:  Mark Thackham; Jun Ma
Journal:  J Appl Stat       Date:  2019-10-31       Impact factor: 1.416

4.  Dose-Response and Dose-Toxicity Relationships for Glass 90Y Radioembolization in Patients with Liver Metastases from Colorectal Cancer.

Authors:  Ahmed A Alsultan; Caren van Roekel; Maarten W Barentsz; Maarten L J Smits; Britt Kunnen; Miriam Koopman; Arthur J A T Braat; Rutger C G Bruijnen; Bart de Keizer; Marnix G E H Lam
Journal:  J Nucl Med       Date:  2021-03-19       Impact factor: 10.057

5.  PSHREG: a SAS macro for proportional and nonproportional subdistribution hazards regression.

Authors:  Maria Kohl; Max Plischke; Karen Leffondré; Georg Heinze
Journal:  Comput Methods Programs Biomed       Date:  2014-12-03       Impact factor: 5.428

6.  Identification of genetic modifiers of age-at-onset for familial Parkinson's disease.

Authors:  Erin M Hill-Burns; Owen A Ross; William T Wissemann; Alexandra I Soto-Ortolaza; Sepideh Zareparsi; Joanna Siuda; Timothy Lynch; Zbigniew K Wszolek; Peter A Silburn; George D Mellick; Beate Ritz; Clemens R Scherzer; Cyrus P Zabetian; Stewart A Factor; Patrick J Breheny; Haydeh Payami
Journal:  Hum Mol Genet       Date:  2016-07-11       Impact factor: 6.150

7.  Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck.

Authors:  Thomas J W Klein Nulent; Matthijs H Valstar; Laura A Smit; Ludwig E Smeele; Nicolaas P A Zuithoff; Bart de Keizer; Remco de Bree; Robert J J van Es; Stefan M Willems
Journal:  BMC Cancer       Date:  2020-06-05       Impact factor: 4.430

8.  Early outcome of a 31-gene expression profile test in 86 AJCC stage IB-II melanoma patients. A prospective multicentre cohort study.

Authors:  S Podlipnik; C Carrera; A Boada; N A Richarz; J L López-Estebaranz; F Pinedo-Moraleda; M Elosua-González; M M Martín-González; R Carrillo-Gijón; P Redondo; E Moreno; J Malvehy; S Puig
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-02-28       Impact factor: 6.166

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.